Treatment Algorithms for Hypertensive Patients with Hyperlipidaemia and Diabetes, Including Management Beyond Triple Combination Therapy

by Prateek Chopra | June 7, 2026 | Cardiology Conferences | ESH 2026 Optimizing Cardiovascular Risk: Prof. Andrzej highlighted standardized CVD mortality rates across regions, emphasizing major risk factors including BMI, systolic blood pressure, non-HDL cholesterol, diabetes, and smoking. Expanded clinical conditions such as resistant hypertension, sleep disorders, chronic inflammation, NAFLD, and migraine, as well as emerging risk factors like sedentary

Treatment Algorithms for Hypertensive Patients with Hyperlipidaemia and Diabetes, Including Management Beyond Triple Combination Therapy Read Post »